Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2014 - 2016)

Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Current Leases of $4000.0 for Q4 2016, down 95.45% year-over-year from $88000.0 in Q1 2016, and down 95.45% quarter-over-quarter from $88000.0 in Q4 2015.

Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2014 - 2016) Analysis & Trends

Viridian Therapeutics, Inc.\DE's Current Leases history runs 3 years deep, the most recent figure standing at $4000.0 for Q4 2016.

  • In Q4 2016, Current Leases fell 95.45% year-over-year to $4000.0; the TTM figure through Dec 2016 stood at $4000.0 (down 95.45% YoY), while the FY2016 annual figure was $4000.0, down 95.45% from the prior year.
  • Current Leases for Q4 2016 stood at $4000.0, down from $88000.0 in the prior quarter.
  • The five-year high for Current Leases was $88000.0 in Q4 2015, with the low at $4000.0 in Q4 2016.
  • The 3-year median for Current Leases is $80000.0 (2014), against an average of $57333.3.
  • The sharpest annual moves came in 2015 and 2016: Current Leases increased 10.0% in 2015, then slumped 95.45% in 2016.
  • Viridian Therapeutics, Inc.\DE's Current Leases stood at $80000.0 in 2014, then climbed by 10.0% to $88000.0 in 2015, then plunged by 95.45% to $4000.0 in 2016.
  • Business Quant data shows VRDN's Current Leases at $4000.0 in Q4 2016, $88000.0 in Q4 2015, and $80000.0 in Q4 2014.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 11.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 16.75 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 21.95 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2.24 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 45.93 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 6.27 Mn
10 Viridian Therapeutics, Inc.\DE 2.50 Bn 2.50 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 4,000.00
Dec 31, 2015 88,000.00
Dec 31, 2014 80,000.00